Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ANZUPGO (delgocitinib)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ANZUPGO (delgocitinib)

Medicine - Posted on Apr 30 2025
Active substance (DCI)
  • delgocitinib
history (1)
  • 3/26/25

    ANZUPGO (delgocitinib) - Eczéma chronique des mains (ECM)

    Inscription L'essentiel Avis favorable au remboursement dans le traitement de l’eczéma chronique des mains (ECM) modéré à sé...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • D11AH11
Manufacturer
LEO PHARMA
Presentation

ANZUPGO 20 mg/g, crème
Boite de 1 tube de 60 g (CIP : 34009 303 030 9 2)

All our publications
    Drug therapy Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
SL0bt0WztwyxS9X1